GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,752,982 | -1.8% | 75,589 | +17.8% | 0.01% | +12.5% |
Q2 2023 | $3,820,026 | -21.1% | 64,159 | -24.9% | 0.01% | -27.3% |
Q1 2023 | $4,838,699 | -23.7% | 85,429 | 0.0% | 0.01% | -31.2% |
Q4 2022 | $6,344,812 | +20.6% | 85,429 | -3.3% | 0.02% | +14.3% |
Q3 2022 | $5,262,000 | +6.1% | 88,339 | 0.0% | 0.01% | +16.7% |
Q2 2022 | $4,959,000 | -25.4% | 88,339 | -1.9% | 0.01% | -7.7% |
Q1 2022 | $6,644,000 | +4.1% | 90,057 | +1.9% | 0.01% | +18.2% |
Q4 2021 | $6,381,000 | +1.1% | 88,375 | +7.3% | 0.01% | -8.3% |
Q3 2021 | $6,311,000 | -1.2% | 82,364 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $6,386,000 | +12.6% | 82,364 | -10.4% | 0.01% | +9.1% |
Q1 2021 | $5,672,000 | -6.0% | 91,971 | -0.6% | 0.01% | -8.3% |
Q4 2020 | $6,034,000 | +34.7% | 92,511 | +2.3% | 0.01% | +20.0% |
Q3 2020 | $4,478,000 | +5.0% | 90,432 | +1.1% | 0.01% | -9.1% |
Q2 2020 | $4,266,000 | +61.8% | 89,408 | +44.2% | 0.01% | +37.5% |
Q1 2020 | $2,637,000 | +8.5% | 62,000 | +50.2% | 0.01% | +33.3% |
Q4 2019 | $2,430,000 | +13.3% | 41,265 | -1.6% | 0.01% | 0.0% |
Q3 2019 | $2,145,000 | +20.8% | 41,955 | 0.0% | 0.01% | +20.0% |
Q2 2019 | $1,775,000 | -5.9% | 41,955 | +9.9% | 0.01% | 0.0% |
Q1 2019 | $1,886,000 | +15.0% | 38,178 | +0.8% | 0.01% | 0.0% |
Q4 2018 | $1,640,000 | -7.9% | 37,886 | +20.8% | 0.01% | 0.0% |
Q3 2018 | $1,780,000 | -8.2% | 31,360 | -18.3% | 0.01% | 0.0% |
Q2 2018 | $1,938,000 | -20.9% | 38,401 | -21.9% | 0.01% | -28.6% |
Q1 2018 | $2,449,000 | +50.2% | 49,147 | +23.8% | 0.01% | +75.0% |
Q4 2017 | $1,631,000 | +234.9% | 39,683 | +142.0% | 0.00% | +300.0% |
Q3 2017 | $487,000 | -10.5% | 16,396 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $544,000 | +11.9% | 16,396 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $486,000 | +19.4% | 16,396 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $407,000 | +10.0% | 16,396 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $370,000 | -34.5% | 16,396 | -30.8% | 0.00% | -50.0% |
Q2 2016 | $565,000 | +0.9% | 23,699 | +0.5% | 0.00% | 0.0% |
Q1 2016 | $560,000 | -9.4% | 23,572 | +6.2% | 0.00% | 0.0% |
Q4 2015 | $618,000 | +46.4% | 22,198 | +8.7% | 0.00% | 0.0% |
Q3 2015 | $422,000 | -19.5% | 20,412 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $524,000 | +79.5% | 20,412 | +76.7% | 0.00% | +100.0% |
Q1 2015 | $292,000 | +15.0% | 11,553 | +8.1% | 0.00% | 0.0% |
Q4 2014 | $254,000 | +21.0% | 10,689 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $210,000 | -18.0% | 10,689 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $256,000 | – | 10,689 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |